Literature DB >> 16762917

Knockdown of MBP-1 in human prostate cancer cells delays cell cycle progression.

Asish K Ghosh1, Robert Steele, Ratna B Ray.   

Abstract

We have previously shown that MBP-1 acts as a general transcriptional repressor, and forced expression of MBP-1 exerts an anti-proliferative effect on a number of human cancer cells. In this report, we have investigated the role of endogenous MBP-1 in cell growth regulation. For this, we generated human prostate cancer cells (PC3) stably transfected with short hairpin RNA targeting MBP-1. We have observed retarded growth and longer doubling time of MBP-1 knockdown PC3 cells as compared with control mock-transfected PC3 cells. Fluorescence-activated cell sorter analysis suggested that PC3 cells expressing MBP-1-specific small interfering RNA accumulated during G2/M phase of the cell cycle. Further analysis suggested that depletion of MBP-1 was associated with reduction of cyclin A and cyclin B1 expression when compared with that of the control cells. A delayed induction of cyclin A and B1 expression was observed in MBP-1-depleted PC3 cells (PC3-4.2) upon serum stimulation, although the level of expression was much lower than that of control PC3 cells. Supplementation of MBP-1 in PC3-4.2 cells restored cyclin A and cyclin B1 expression. Together, these results suggest that knockdown of MBP-1 in prostate cancer cells perturbs cell proliferation by inhibiting cyclin A and cyclin B1 expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16762917     DOI: 10.1074/jbc.M602930200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  4-O-methylhonokiol, a PPARγ agonist, inhibits prostate tumour growth: p21-mediated suppression of NF-κB activity.

Authors:  N J Lee; J H Oh; J O Ban; J H Shim; H P Lee; J K Jung; B W Ahn; D Y Yoon; S B Han; Y W Ham; J T Hong
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

2.  MBP-1 suppresses growth and metastasis of gastric cancer cells through COX-2.

Authors:  Kai-Wen Hsu; Rong-Hong Hsieh; Chew-Wun Wu; Chin-Wen Chi; Yan-Hwa Wu Lee; Min-Liang Kuo; Kou-Juey Wu; Tien-Shun Yeh
Journal:  Mol Biol Cell       Date:  2009-12       Impact factor: 4.138

Review 3.  Androgen receptor on the move: boarding the microtubule expressway to the nucleus.

Authors:  Maria Thadani-Mulero; David M Nanus; Paraskevi Giannakakou
Journal:  Cancer Res       Date:  2012-09-15       Impact factor: 12.701

4.  Myc promoter-binding protein-1 (MBP-1) is a novel potential prognostic marker in invasive ductal breast carcinoma.

Authors:  Mariavera Lo Presti; Arianna Ferro; Flavia Contino; Claudia Mazzarella; Silvia Sbacchi; Elena Roz; Carmelo Lupo; Giovanni Perconti; Agata Giallongo; Paola Migliorini; Antonio Marrazzo; Salvatore Feo
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

5.  Enolase-1 is a therapeutic target in endometrial carcinoma.

Authors:  Mengyang Zhao; Weiyi Fang; Yan Wang; Suiqun Guo; Luyun Shu; Lijing Wang; YiYu Chen; Qiaofen Fu; Yan Liu; Shengni Hua; Yue Fan; Yiyi Liu; Xiaojie Deng; Rongcheng Luo; Zhong Mei; Qinping Jiang; Zhen Liu
Journal:  Oncotarget       Date:  2015-06-20

Review 6.  The Biological Significance and Regulatory Mechanism of c-Myc Binding Protein 1 (MBP-1).

Authors:  Zijin Liu; Aileen Zhang; Lamei Zheng; Abou-Fadel Johnathan; Jun Zhang; Genfa Zhang
Journal:  Int J Mol Sci       Date:  2018-12-04       Impact factor: 5.923

7.  Epigenetics in prostate cancer treatment.

Authors:  Katelyn Jones; Yanquan Zhang; Yifan Kong; Elia Farah; Ruixin Wang; Chaohao Li; Xinyi Wang; ZhuangZhuang Zhang; Jianlin Wang; Fengyi Mao; Xiaoqi Liu; Jinghui Liu
Journal:  J Transl Genet Genom       Date:  2021-08-27

8.  Knockdown of MBP-1 in human foreskin fibroblasts induces p53-p21 dependent senescence.

Authors:  Asish K Ghosh; Tatsuo Kanda; Robert Steele; Ratna B Ray
Journal:  PLoS One       Date:  2008-10-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.